| VANDA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US9216591084 / A0JJT3 |
| VM4 (Frankfurt) / VNDA (NASDAQ) |
| FRA:VM4, ETR:VM4, VM4:GR, NASDAQ:VNDA |
| - |
| https://www.vandapharma.c.. |
|
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies addressing high unmet medical needs in areas such as sleep-wake disorders, psychiatric and neurologic conditions, motion sickness,..
>Volltext.. |
| 362.03 Mio. EUR |
| 148.14 Mio. EUR |
| 187.21 Mio. EUR |
| -120.64 Mio. EUR |
| -191 Mio. EUR |
| -3.24 EUR |
| 10.93 Mio. EUR |
| 73.6 Mio. EUR |
| -94.81 Mio. EUR |
| 1.82 |
| -4.17% |
| -928.19% |
| - |
| - |
| - |
| - |
| VANDA |
| 05.04.26 |
|